TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30759696

Group type: EXPERIMENTAL
Intervention: Moderately hypofractionated radiation therapy (240-340 cGy per fraction)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrahypofractionated radiation therapy (500 cGy or more per fraction)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ultrahypofractionated external beam radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Image guided radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonmodulated 3-dimensional conformal techniques
Number of subjects: 0
Study: 28971842

Group type: EXPERIMENTAL
Intervention: Beetroot powder containing inorganic nitrate (BRA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (beetroot powder devoid of inorganic nitrate, BRP)
Number of subjects: 13
Study: 27711118

Group type: EXPERIMENTAL
Intervention: Hands-on practical workshop
Number of subjects: 0

Group type: COMPARATOR
Intervention: Discussion or lecture
Number of subjects: 0
Study: 24267728

Group type: EXPERIMENTAL
Intervention: Emollient combining glycerol and paraffin
Number of subjects: 251

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 251
Study: 22917200

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Older age and less severe ADHD symptoms
Number of subjects: 279
Study: 19545360

Group type: EXPERIMENTAL
Intervention: Standard intact cow milk protein formula (INTACT)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Partially hydrolyzed cow milk protein formula (PH)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Overall study discontinuance based on parent-assessed intolerance
Number of subjects: 335

Group type: COMPARATOR
Intervention: Overall study discontinuance based on study physician-assessed intolerance
Number of subjects: 335
Study: 17527035

Group type: EXPERIMENTAL
Intervention: Low-iron diet for six months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Phlebotomy biweekly
Number of subjects: 40
Study: 15170704

Group type: EXPERIMENTAL
Intervention: Eptifibatide (Integrilin)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Heparin only (Control)
Number of subjects: 300
Study: 11673318

Group type: EXPERIMENTAL
Intervention: Visual and motor evoked potentials (VEP and MEP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined latencies of VEP and MEP using the sum of their Z scores
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Electrophysiological data and EDSS changes over time
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Baseline VEP and MEP
Number of subjects: 30
Study: 9638493

Group type: EXPERIMENTAL
Intervention: Transrectal ultrasonography
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Electromyography and rectal sensitivity studies
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 25
Study: 8088394

Group type: EXPERIMENTAL
Intervention: Allopurinol 200 mg orally at 24 h and 2 h preoperatively and again at 24 h postoperatively
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 29
Study: 2683005

Group type: EXPERIMENTAL
Intervention: Alpha human leukocyte interferon (IFN) ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1194512

Group type: EXPERIMENTAL
Intervention: Alcohol (vodka and tonic)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Nonalcoholic beverage (tonic water)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Provocation to aggress
Number of subjects: 96

Group type: COMPARATOR
Intervention: Neutral interaction (control condition)
Number of subjects: 96
Study: 30656549

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) with cow's milk protein free diet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo with milk-free diet
Number of subjects: 100
Study: 31470798

Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (BZK)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Povidone iodine (PVI)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: In vitro growth inhibitory activity
Number of subjects: 50
Study: 27909881

Group type: EXPERIMENTAL
Intervention: Recruitment message with pride emotional appeal
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Recruitment message with financial incentive
Number of subjects: 199

Group type: COMPARATOR
Intervention: Other ad hoc messages
Number of subjects: 199
Study: 26398912

Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted total gastrectomy
Number of subjects: 753

Group type: COMPARATOR
Intervention: Open total gastrectomy
Number of subjects: 753
Study: 23511717

Group type: EXPERIMENTAL
Intervention: Functional remediation
Number of subjects: 239

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 239

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 239
Study: 21678716

Group type: EXPERIMENTAL
Intervention: six-week treatment regimen for type 1 diabetes
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: self-reported questionnaires
Number of subjects: 8
Study: 19284948

Group type: EXPERIMENTAL
Intervention: Changjishu soft elastic capsule (4 capsules once daily, 3 times a day)
Number of subjects: 104
Study: 16702330

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified seasoning powder (zinc 5 mg, iron 5 mg, vitamin A 270 microg, iodine 50 microg) served with school lunch 5 days/week for 31 weeks
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified seasoning powder
Number of subjects: 569
Study: 15277727

Group type: EXPERIMENTAL
Intervention: Spironolactone (Spi)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 168
Study: 10837943

Group type: EXPERIMENTAL
Intervention: Group 1 (GS = 2-6, T1-2Nx)
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Group 2 (GS = 2-6, T3Nx; or GS = 2-6, N+; or GS = 7, T1-2Nx)
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Group 3 (T3Nx, GS = 7; or N+, GS = 7; or T1-2Nx, GS = 8-10)
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Group 4 (T3Nx, GS = 8-10; or N+, GS = 8-10)
Number of subjects: 1557
Study: 9093172

Group type: EXPERIMENTAL
Intervention: Ispaghula (dietary fibre)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard preparation of bisacodyl
Number of subjects: 0
Study: 1283191

Group type: EXPERIMENTAL
Intervention: Nilvadipine
Number of subjects: 659

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 659
Study: 3963953

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride
Number of subjects: 28

Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 28
Study: 29181560

Group type: EXPERIMENTAL
Intervention: Patient-Specific Instrumentation (PSI)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional Instrumentation (CI)
Number of subjects: 42
Study: 25145587

Group type: EXPERIMENTAL
Intervention: Tailored self-efficacy intervention
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study: 25499943

Group type: EXPERIMENTAL
Intervention: Mipomersen therapy
Number of subjects: 7
Study: 23600790

Group type: EXPERIMENTAL
Intervention: Gaviscon Advance (GA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Antacid (Milk of Magnesia)
Number of subjects: 20
Study: 20870219

Group type: EXPERIMENTAL
Intervention: Safety behavior use (SBU)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No safety behavior use (NSB)
Number of subjects: 43
Study: 18258624

Group type: EXPERIMENTAL
Intervention: Diet rich in n-3 PUFAs (3.5% of energy intake)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control diet (0.5% of energy intake from n-3 PUFAs)
Number of subjects: 26
Study: 17007162

Group type: EXPERIMENTAL
Intervention: Educational intervention 1
Number of subjects: 754

Group type: EXPERIMENTAL
Intervention: Educational intervention 2
Number of subjects: 754

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 754

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 754
Study: 12748410

Group type: EXPERIMENTAL
Intervention: Vegetarians
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Vegans
Number of subjects: 81

Group type: COMPARATOR
Intervention: Mixed diet
Number of subjects: 81
Study: 10910606

Group type: EXPERIMENTAL
Intervention: HBV-NF vaccine
Number of subjects: 116

Group type: COMPARATOR
Intervention: Engerix-B vaccine
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 116
Study: 7722114

Group type: EXPERIMENTAL
Intervention: Carvedilol (3.125 mg twice a day, titrated to 6.25 to 25 mg twice a day for < 75 kg or 50 mg twice a day for > 75 kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 2047947

Group type: EXPERIMENTAL
Intervention: Salbutamol 1,000 micrograms by inhalation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Salbutamol 200 micrograms by inhalation
Number of subjects: 23
Study: 7358871

Group type: EXPERIMENTAL
Intervention: Morning scheduling (A.M.)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Afternoon scheduling (P.M.)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Overall measures
Number of subjects: 16
Study: 31483150

Group type: EXPERIMENTAL
Intervention: Jogging and foam-rolling exercises (8 minutes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Jogging (8 minutes)
Number of subjects: 30
Study: 28639346

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (1,250 kcal/d) for 12 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Very-low-calorie diet (500 kcal/d) for 5 weeks followed by a 4-week weight-stable period
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dietary intervention (DI) period
Number of subjects: 16
Study: 25994838

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg once daily
Number of subjects: 2850

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg once daily
Number of subjects: 2850

Group type: COMPARATOR
Intervention: Aspirin 100 mg daily
Number of subjects: 2850
Study: 22707179

Group type: EXPERIMENTAL
Intervention: Dignity therapy (palliative care psychotherapy)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Research participation (regardless of intervention)
Number of subjects: 49
Study: 22078241

Group type: EXPERIMENTAL
Intervention: mDOT (directly observed daily ribavirin plus provider-administered weekly IFN)
Number of subjects: 80

Group type: COMPARATOR
Intervention: TAU (self-administered ribavirin plus provider-administered weekly IFN)
Number of subjects: 80
Study: 19735340

Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention
Number of subjects: 203

Group type: COMPARATOR
Intervention: Routine information preparation
Number of subjects: 203
Study: 16402259

Group type: EXPERIMENTAL
Intervention: Working memory task in AD patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Working memory task in MCI patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Working memory task in controls
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Comparison of AD and MCI groups
Number of subjects: 30
Study: 15157731

Group type: EXPERIMENTAL
Intervention: Earlier treatment of peripheral retina ablation
Number of subjects: 401

Group type: COMPARATOR
Intervention: Conventional management of peripheral retina ablation
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Retinal structure assessment
Number of subjects: 401
Study: 11782323

Group type: EXPERIMENTAL
Intervention: BIS group (isoflurane titrated to maintain BIS value between 50-60)
Number of subjects: 68

Group type: COMPARATOR
Intervention: SP group (standard practice, anesthesiologists blinded to BIS value)
Number of subjects: 68
Study: 9836158

Group type: EXPERIMENTAL
Intervention: Educational handout about colposcopy mailed one week before appointment
Number of subjects: 113

Group type: COMPARATOR
Intervention: No mailed handout (control group)
Number of subjects: 113
Study: 7662924

Group type: EXPERIMENTAL
Intervention: The Circle of Life teaching strategy
Number of subjects: 43
Study: 2719902

Group type: EXPERIMENTAL
Intervention: Cimetidine (200 mg three times daily and 400 mg at night)
Number of subjects: 5
Study: 944022

Group type: EXPERIMENTAL
Intervention: Sucrose addition to electrolyte mixture
Number of subjects: 94

Group type: COMPARATOR
Intervention: Glucose addition to electrolyte mixture
Number of subjects: 94
Study: 6175933

Group type: EXPERIMENTAL
Intervention: cis-diamminodichloroplatinum (II) plus Bleomycin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Methotrexate and vindesine
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Primary chemotherapy (pc)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Secondary chemotherapy (sc)
Number of subjects: 33
Study: 30859909

Group type: EXPERIMENTAL
Intervention: Nurse Navigators (NNs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Historical Control Group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Concurrent Control Group
Number of subjects: 100
Study: 30227301

Group type: EXPERIMENTAL
Intervention: Glutathione 30 mg L-1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Glutathione 50 mg L-1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Glutathione 40 mg L-1
Number of subjects: 6

Group type: COMPARATOR
Intervention: Glutathione 0 mg L-1 (control)
Number of subjects: 6
Study: 26946727

Group type: EXPERIMENTAL
Intervention: Moxibustion (once a day, 15-20 min each time, till local skin turned slightly red)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diclofenac sodium (0.3 g twice a day), Methotrexate (10 mg once a week), Folic acid (5 mg once a week)
Number of subjects: 40
Study: 24799543

Group type: EXPERIMENTAL
Intervention: Advergame promoting energy-dense snacks
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Rewarding children to refrain from eating
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Rewarding impulsive children to refrain from eating while playing an advergame promoting energy-dense snacks
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Rewarding low impulsive children to refrain from eating while playing nonfood advergames
Number of subjects: 261
Study: 21795756

Group type: EXPERIMENTAL
Intervention: Regular walking exercise for 6 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual physical activity (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate supplementation (target venous bicarbonate 29 mmol/L)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Previous sodium bicarbonate treatment (target 24 mmol/L)
Number of subjects: 40
Study: 19955221

Group type: EXPERIMENTAL
Intervention: Joint lavage alone
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Joint lavage combined with IA steroid injection
Number of subjects: 855

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 855
Study: 17363740

Group type: EXPERIMENTAL
Intervention: Lifestyle modification
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 758

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 758
Study: 16324030

Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg.kg(‐1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 120
Study: 12151918

Group type: EXPERIMENTAL
Intervention: Accelerated pathway (n = 131)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard pathway (n = 70)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Overall comparison
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 201
Study: 10445610

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate 2 mg x day(-1)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 7823712

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 2295

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 2295

Group type: EXPERIMENTAL
Intervention: Severe carotid stenosis (70-99%)
Number of subjects: 2295

Group type: COMPARATOR
Intervention: Overall stroke risk
Number of subjects: 2295
Study: 2192383

Group type: EXPERIMENTAL
Intervention: diazepam
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: dothiepin
Number of subjects: 210

Group type: COMPARATOR
Intervention: placebo tablets
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: cognitive and behaviour therapy
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: self‐help package
Number of subjects: 210
Study: 476023

Group type: EXPERIMENTAL
Intervention: Nystatin (100,000 units/day for 14 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clotrimazole (100 mg/day for 6 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Miconazole (100 mg/day for 14 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Miconazole (100 mg twice daily for 7 days)
Number of subjects: 0
Study: 31987323

Group type: EXPERIMENTAL
Intervention: 80 mg/kg VE
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 160 mg/kg VE
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 320 mg/kg VE
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 640 mg/kg VE
Number of subjects: 180
Study: 31013292

Group type: EXPERIMENTAL
Intervention: Challenge appraisal condition featuring orienting information describing benefits of persistence despite discomfort for future life satisfaction
Number of subjects: 235

Group type: COMPARATOR
Intervention: Higher threat appraisal condition featuring task orienting information describing symptoms and consequences of frostbite
Number of subjects: 235

Group type: COMPARATOR
Intervention: Lower threat appraisal condition featuring orienting information about safety of the CPT
Number of subjects: 235
Study: 27995821

Group type: EXPERIMENTAL
Intervention: Assisted reflection on life events and ultimate life goals
Number of subjects: 45
Study: 25885634

Group type: EXPERIMENTAL
Intervention: Randomized exercise intervention trial on cancer‐related fatigue
Number of subjects: 117
Study: 24062180

Group type: EXPERIMENTAL
Intervention: Saroglitazar (ZYH1) at doses of 0.125, 0.25, 0.5, 1, 2, 4, 8, 16, 32, 64, and 128 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Saroglitazar (1 mg)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Saroglitazar (up to 128 mg)
Number of subjects: 96
Study: 22035643

Group type: EXPERIMENTAL
Intervention: Sertraline treatment
Number of subjects: 469

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study: 19124098

Group type: EXPERIMENTAL
Intervention: Prophylactic cement injection into non-fractured vertebra adjacent to fractured vertebra
Number of subjects: 244

Group type: COMPARATOR
Intervention: Non-prophylactic treatment (no cement injection)
Number of subjects: 244
Study: 17848839

Group type: EXPERIMENTAL
Intervention: Subclinical hyperthyroidism (sHT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 24
Study: 15495732

Group type: EXPERIMENTAL
Intervention: 3 mm insole
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 6 mm insole
Number of subjects: 38

Group type: COMPARATOR
Intervention: Current-issue Saran insoles
Number of subjects: 38
Study: 11694667

Group type: EXPERIMENTAL
Intervention: Atomoxetine 1.2 mg/kg/day
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Atomoxetine 1.8 mg/kg/day
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Atomoxetine 0.5 mg/kg/day
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Atomoxetine (all doses)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study: 8981385

Group type: EXPERIMENTAL
Intervention: Scopolamine (0.5 mg i.v.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Haloperidol (2 mg p.o.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metergoline (4 mg p.o.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Haloperidol (2 mg p.o.) + Scopolamine (0.5 mg i.v.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metergoline (4 mg p.o.) + Scopolamine (0.5 mg i.v.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8518376

Group type: EXPERIMENTAL
Intervention: Computer-assisted continuous infusion (CACI)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Manual controlled infusion (MCI)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 2881575

Group type: EXPERIMENTAL
Intervention: Topical dimethindene maleate
Number of subjects: 16
Study: 31236568

Group type: EXPERIMENTAL
Intervention: COBRA-Slim (MTX, prednisone step-down from 30 mg)
Number of subjects: 379

Group type: COMPARATOR
Intervention: COBRA-Classic (MTX, sulfasalazine, prednisone step-down from 60 mg)
Number of subjects: 379

Group type: COMPARATOR
Intervention: COBRA-Avant-Garde (MTX, leflunomide, prednisone step-down from 30 mg)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Tight Step Up (TSU) (MTX without prednisone)
Number of subjects: 379

Group type: COMPARATOR
Intervention: COBRA-Classic
Number of subjects: 379

Group type: COMPARATOR
Intervention: COBRA-Avant-Garde
Number of subjects: 379
Study: 27834686

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg) and folic acid (0.8 mg)
Number of subjects: 10783

Group type: COMPARATOR
Intervention: Enalapril (10 mg) alone
Number of subjects: 10783
Study: 26623405

Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron (Group O)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone (Group D)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron + 8 mg dexamethasone (Group OD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 90
Study: 23993109

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (bemiparin) for 10 days at a prophylactic dose, early ambulation, and compression therapy for 3 months
Number of subjects: 262

Group type: COMPARATOR
Intervention: Early ambulation and compression therapy alone
Number of subjects: 262
Study: 21533663

Group type: EXPERIMENTAL
Intervention: Intracuff pressure of 80 cm H(2)O
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Intracuff pressure of 60 cm H(2)O
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Intracuff pressure of 40 cm H(2)O
Number of subjects: 123

Group type: COMPARATOR
Intervention: Postoperative pharyngolaryngeal adverse events
Number of subjects: 123

Group type: COMPARATOR
Intervention: Patient satisfaction scores
Number of subjects: 123

Group type: COMPARATOR
Intervention: Anesthesiologist satisfaction scores
Number of subjects: 123
Study: 18194979

Group type: EXPERIMENTAL
Intervention: Valsartan (80-160 mg/d)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Metoprolol (50-100 mg/d)
Number of subjects: 68